A Case-Based Focus on Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Gain expert insights on the application of current and emerging therapies for the treatment of neurofibromatosis type 1 and inoperable plexiform neurofibromas. This program will feature downloadable slides and an on-demand webcast from a live satellite symposium and an expert commentary.

Share

Program Content

Activities

NF1 and Inoperable Plexiform Neurofibromas
A Case-Based Focus on Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2022

Expires: July 07, 2023

View Activity

Activities

NF1 and Inoperable PNs
Key Points in the Management of Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2022

Expires: July 17, 2023

View Activity

Activities

NF1 Inoperable PNF: Targeted Tx
Disease Overview and Role of Targeted Treatment in NF1-Associated Inoperable Plexiform Neurofibromas
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 20, 2022

Expires: June 19, 2023

View Activity
NF1 PNF: Clinical Considerations
Clinical Considerations in the Management of NF1-Associated Inoperable Plexiform Neurofibromas and Case Discussion
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 20, 2022

Expires: June 19, 2023

View Activity

Faculty

cover img faculity

Miriam Bornhorst, MD

Clinical Director 
Gilbert Neurofibromatosis Clinic
Medical Director 
Cancer Genetics Clinic
Attending Neuro-oncologist
Department of Neurology and Oncology
Center for Genetics Medicine Research
Children's National Hospital
Assistant Professor of Pediatrics
George Washington University
Washington, D.C.

cover img faculity

Carlos Romo, MD

Assistant Professor of Neurology, Oncology and Medicine Director of Clinical Research
The Neurofibromatosis Therapeutic Acceleration Program
Department of Neurology
Johns Hopkins University School of Medicine
Baltimore, Maryland

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Alexion Pharmaceuticals